Press releases | WebDisclosure

Basculer en Français

10965	Companies
240137	Keywords
168910	Articles
129231	Press releases

Home
Press releases

PRESS RELEASE

published on 05/23/2024 at 07:00, 2 years 3 months ago

EUROAPI strengthens its presence in animal health with a €130-150 million supply contract
EUROAPI strengthens its presence in animal health with a €130-150 million supply contract, supporting the FOCUS-27 project sales trajectory. The agreement highlights EUROAPI's expertise and reliability in CMO services

Animal Health EUROAPI Supply Contract FOCUS-27 Project CMO Services
PRESS RELEASE

published on 05/23/2024 at 07:00, 2 years 3 months ago

EUROAPI renforce sa présence en santé animale avec un contrat de fourniture de 130-150 millions d’euros
EUROAPI renforce sa présence en santé animale avec un contrat de fourniture de 130-150 millions d'euros, soutenant la trajectoire de ventes du projet FOCUS-27, témoignant du savoir-faire et de la fiabilité des services premium

Santé Animale EUROAPI Contrat De Fourniture Contract Manufacturing Organization FOCUS-27
PRESS RELEASE

published on 05/23/2024 at 06:58, 2 years 3 months ago

DocMorris AG: Early redemption of the 2.75% Convertible Bonds due 2025
DocMorris AG announces the early redemption of 2.75% Convertible Bonds due 2025 in accordance with set conditions. Bondholders should act promptly

Convertible Bonds Bondholders Early Redemption Announcement DocMorris AG
PRESS RELEASE

published on 05/23/2024 at 06:45, 2 years 3 months ago

Galenica maintient le cap avec une croissance du chiffre d’affaires
Galenica maintient sa croissance avec une hausse de 4.8% de son chiffre d'affaires pour les quatre premiers mois de 2024. Perspectives confirmées pour 2024

Chiffre D'affaires Croissance Résultat De Ventes Perspectives 2024 Galenica AG
PRESS RELEASE

published on 05/23/2024 at 06:45, 2 years 3 months ago

Galenica on track with sales growth
Galenica Group reports 4.8% sales growth in the first four months of 2024, driven by positive pharmaceutical market development. Outlook for 2024 confirmed with sales growth between 3% and 5%

Sales Growth Outlook 2024 Galenica Group Pharmaceutical Market
PRESS RELEASE

published on 05/23/2024 at 06:30, 2 years 3 months ago

Carsten Franke appointed Chief Operations Officer
Carsten Franke appointed as Chief Operations Officer (COO) of dormakaba Holding AG, bringing strong expertise in operational excellence and supply chain optimization. CEO Till Reuter welcomes his leadership for ongoing transformation program

Transformation Program Chief Operations Officer Supply Chain Optimization Carsten Franke Dormakaba Holding AG
PRESS RELEASE

published on 05/23/2024 at 06:16, 2 years 3 months ago

EQS-Adhoc: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed
Gerresheimer AG announces acquisition of Blitz LuxCo Sarl, the holding company of Bormioli Pharma Group, for around EUR 800 million. Strategic review planned for Moulded Glass business

Acquisition Gerresheimer AG Blitz LuxCo Sarl Bormioli Pharma Group Moulded Glass Business
PRESS RELEASE

published on 05/23/2024 at 00:20, 2 years 3 months ago

The Game Has Changed - 3 Day Free Virtual Live Event Hosted by Dean Graziosi & Tony Robbins
Tony Robbins & Dean Graziosi announce a landmark three-day 'The Game Has Changed - Virtual Live Event' to empower individuals with success strategies in the Knowledge Economy

Personal Development Tony Robbins Dean Graziosi Virtual Live Event Success Blueprint
PRESS RELEASE

published on 05/23/2024 at 00:00, 2 years 3 months ago

Avino Silver & Gold Mines Ltd. Reminds Shareholders to Vote in Advance of Deadline for 2024 AGM
Avino Silver & Gold Mines Ltd. reminds shareholders of the upcoming Annual General Meeting on May 30, 2024. Shareholders urged to vote before May 28, 2024. Online and telephone voting options available

Annual General Meeting Shareholders Avino Silver & Gold Mines Ltd. Proxy Voting
PRESS RELEASE

published on 05/22/2024 at 23:15, 2 years 3 months ago

APPULSE CORPORATION - Reporting Results for the Three Months Ended March 31, 2024
Appulse Corporation reports financial results for the first quarter of 2024, including the sale of subsidiary CUI and net loss. Dividend declared for shareholders

Financial Results Dividend Declaration Net Loss Appulse Corporation Sale Of Subsidiary

Accesswire

Published on 09/12/2026 at 02:35, 6 hours 7 minutes ago

Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 9 hours 42 minutes ago

Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 10 hours 37 minutes ago

Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 11 hours 17 minutes ago

Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 15 hours 42 minutes ago

Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

View all ACCESSWIRE

EQS Group

Published on 09/12/2026 at 07:30, 1 hour 11 minutes ago

NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 10 hours 26 minutes ago

Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 10 hours 31 minutes ago

Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 12 hours 57 minutes ago

DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 14 hours 26 minutes ago

CGTN: How BRICS creates new opportunities for Global South development

Les Echos

Published on 09/11/2026 at 07:00, 1 day 1 hour ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 1 day 1 hour ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 1 day 1 hour ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 1 hour ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 13 hours ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE